Bangladesh has approved the Oxford University-AstraZeneca coronavirus vaccine for emergency use, paving the way for importing the vaccine from Serum Institute of India.

Bangladesh's drug administration gave Beximco Pharmaceuticals Ltd, the local partner of Serum, the no-objection certificate (NOC) required to import the shots branded Covishield.

The government is likely to make half the payment today in advance for the three crore/30 million doses of the much-sought-after vaccine.

https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022405